Skip to main content
MRKR logo

MRKR · Marker Therapeutics, Inc. · Executive Compensation

Track MRKR — free
$1.09 -0.23 (-17.42%) At close · Nov 20 Q1 2021 earnings call transcript
Market Cap
$18.17M
Shares
16.67M
Volume · Nov 20 1.97M Avg daily vol (3M) 703.97K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Juan Vera $741,190
Fiscal 2024
Executive Total
Juan Vera $400,000
Fiscal 2023
Executive Total
Peter Hoang $582,394
Juan Vera $581,923
Michael Loiacono $566,515
Mythili Koneru $220,146
Fiscal 2022
Executive Total
Anthony Kim $929,170
Mythili Koneru $632,382
Juan Vera $581,923
Peter Hoang $556,170
Michael Loiacono $479,161
Fiscal 2021
Executive Total
Peter Hoang $1,619,032
Anthony Kim $948,291
Mythili Koneru $901,538
Fiscal 2020
Executive Total
Peter Hoang $1,374,082
Anthony Kim $829,306
Mythili Koneru $782,200
Fiscal 2019
Executive Total
Mythili Koneru $1,843,763
Peter Hoang $451,665
Anthony Kim $431,523

Executive changes

Person Change Filed
Kathryn Penkus Corzo Appointed 2025-11-05
John Wilson Resigned 2025-01-30
Juan Vera Appointed 2023-11-20
Eliot M. Lurier Terminated 2023-11-20
Eliot M. Lurier Appointed 2023-07-03
Michael Loiacono Terminated 2023-07-03
Peter Hoang
“Mr. Hoang's decision to leave the Board was not based on any disagreement with the Company or its management.”
Resigned 2023-05-01
Peter Hoang
“Mr. Hoang's decision to leave the Board was not based on any disagreement with the Company or its management.”
Resigned 2023-05-01
Mythili Koneru Resigned 2023-03-16
Anthony Kim Terminated 2022-09-27
Katharine Knobil, M.D. Appointed 2021-12-09
Juan Vera Appointed 2021-11-15
Juan Vera Appointed 2021-11-15

Leadership

Key facts CIK 1094038 CUSIP 57055L206 13F (30d) 51 filings 34 filers Visit website Investor relations